Belimumab is now the first and only subcutaneous biologic therapy approved for at-home administration in pediatric lupus nephritis.

If you're interested in exploring more stocks under $10 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Investing in stocks under $10 could ...

IPC Indice de Precios Y Cotizaciones 56,097.71-166.98-0.30% ...